Phacilitate Leaders Forum

29TH - 30TH SEPTEMBER 2020


Sponsors & Exhibitors 2018


Bronze Sponsor

MolMed SpA is an Italian Cell&Gene therapy company focused on research, development, manufacturing and clinical validation of innovative therapies in oncology and genetic rare diseases. MolMed built an original dual business model, including a proprietary pipeline in onco-hematology, and a third party service business focused on development and GMP manufacturing of retroviral/lentiviral vector up to 200L batches and ex-vivo transduction of hematopoietic stem cells and T-cells. MolMed owns two of the first GMP facilities authorized in Europe for commercial Cell&Gene therapy products, serving relevant international partners, such as GSK, Orchard, Telethon, Cellectis, Rocket Pharma and undisclosed others. Founded in 1996 as an academic spin-off of the San Raffaele Scientific Institute, one of the leading private scientific research institutes in Italy, MolMed is listed on the (MTA) Milan Stock Exchange.

Visit Website
View all Sponsors & Exhibitors 2018
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd